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Cancers arise from an accumulation of genetic and epi-
genetic alterations, through which cells acquire the
properties required for malignancy. Unraveling the
sequence of alterations driving tumorigenesis is crucial
to understand the biological mechanisms underlying
tumor initiation, invasive progression and metastasis.
The idea of analyzing several tumor samples, such as
recurrences or metastases, from a single patient has
recently gained popularity in the cancer research com-
munity [1,2].
Here, we present a computational method, TuMult,
for reconstructing the sequence of copy number changes
driving carcinogenesis, based on the analysis of several
tumor samples from the same patient. We demonstrate
the reliability of the method with simulated data, and
describe applications to three different cancers, showing
that TuMult is a valuable tool for the establishment of
clonal relationships between tumor samples and the
identification of chromosome aberrations occurring at
crucial steps in cancer progression. This work was
recently published in Genome Biology [3].
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